CONFIMIDs - Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology)

Head :
DEZOTEUX Frédéric, INSERM U1286 INFINITE

Last update : 05/05/2021 | Version : 1 | ID : 73487

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Evaluation of the impact of the lockdown and easing of restrictions on the management of patients with inflammatory disease and immune disorders followed up as part of the FHU IMMINeNT project (rheumatology, dermatology, internal medicine, pulmonology, gastroenterology and neurology)
Sign or acronym CONFIMIDs
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation 2020-A01596-33
General Aspects
Medical area Dermatology, venereology
Gastroenterology et hepatology
Immunology
Internal medicine
Neurology
Pneumology
Rare diseases
Rheumatology
Study in connection with Covid-19 Yes
Health determinants Healthcare system and access to health care services
Lifestyle and behavior
Occupation
Scientific investigator(s) (Contact)
Name of the director DEZOTEUX
Surname Frédéric
Address Rue Michel Polonovski
Phone 320444193
Unit INSERM U1286 INFINITE
Organization LILLE UNIVERSITY HOSPITAL
Collaborations
Participation in projects, networks and consortia Yes
Funding
Funding status Public
Governance of the database
Sponsor(s) or organisation(s) responsible Lille University Hospital
Organisation status Public
Presence of scientific or steering committees No
Additional contact
Main features
Type of database
Type of database Study databases
Database recruitment is carried out by an intermediary An administrative base or a register
Database recruitment is carried out as part of an interventional study No
Database objective
Main objective Estimate the frequency of patients, with chronic inflammatory disorders, followed up as part of the FHU IMMINeNT project (gastroenterology, rheumatology, dermatology, pulmonology, neurology, internal medicine), whose follow-up has been affected by the lockdown and easing of restrictions.
Inclusion criteria All adult patients followed up as part of the FHU project for:
- Chronic inflammatory bowel disease or IBD (Crohn’s disease and
ulcerative colitis),
- Rheumatic disorders (rheumatoid
arthritis and spondyloarthritis)
- Multiple sclerosis
- Asthma
- Psoriasis
- Atopic dermatitis
- Systemic auto-immune disease (scleroderma and lupus)
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology G00-G09 - Inflammatory diseases of the central nervous system
M34 - Systemic sclerosis
M32 - Systemic lupus erythematosus
L40 - Psoriasis
L20-L30 - Dermatitis and eczema
J45 - Asthma
M05-M14 - Inflammatory polyarthropathies
J84 - Other interstitial pulmonary diseases
K50 - Crohn disease [regional enteritis]
K51 - Ulcerative colitis
L95 - Vasculitis limited to skin, not elsewhere classified
Gender Male
Woman
Other
Geography area Regional
French regions covered by the database Nord - Pas-de-Calais Picardie
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 2020
Date of last collection (YYYY or MM/YYYY) 2020
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 4500
Data
Database activity Data collection completed
Type of data collected Clinical data
Declarative data
Declarative data (detail) Internet self-questionnaire
Presence of a biobank No
Procedures
Participant monitoring No
Followed pathology
Links to administrative sources No
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05